logo

For the Inventor, By the Inventor

Hong Kong, China

Vladimir Aladinskiy

This inventor holds 9 USPTO granted patents and 1 published patent application. Top assignee: Insilico Medicine IP Limited. Active years: 2020-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vladimir Aladinskiy. Retrieved from https://idiyas.com/inventor/vladimir-aladinskiy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 100.0

Average Co-Inventor Count = 3.5

ph-index = 3

Forward Citations = 15(Granted Patents)


Location History:

  • Kaliningrad, RU (2022)
  • Moscow, RU (2020 - 2023)
  • Hong Kong, CN (2021 - 2023)

Company Filing History:

goldMedal9 out of 40 
 
Insilico Medicine IP Limited
 patents

Years Active: 2020-2023

Loading Chart...
9 patents (USPTO):Explore Patents
1. 11807622 - TLR 9 inhibitors (2023-11-07),
2. 11795160 - Kinase inhibitors (2023-10-24),
3. 11739078 - Methods of inhibiting kinases (2023-08-29),
4. 11593660 - Subset conditioning using variational autoencoder with a learnable tensor train induced prior (2023-02-28),
5. 11530199 - Analogs for the treatment of disease (2022-12-20),
6. 11530197 - Analogs for the treatment of disease (2022-12-20),
7. 11008303 - TLR 9 inhibitors (2021-05-18),
8. 10988457 - TLR inhibitors (2021-04-27),
9. 10689360 - TLR inhibitors (2020-06-23),

Title: The Innovative Mind of Vladimir Aladinskiy

Introduction

Vladimir Aladinskiy is a notable inventor based in Hong Kong, China, recognized for his significant contributions to the field of biomedicine through his innovative patents. With a total of nine patents to his name, Aladinskiy is at the forefront of developing novel therapeutic solutions.

Latest Patents

One of his latest patents includes a TLR9 inhibitor, which comprises a compound of general formula (I). Additionally, he has worked on kinase inhibitors, focusing on TNIK and/or MAP4K4 kinase inhibitors, which can include various derivatives and modifications such as Formula A or prodrugs. These innovations signify his commitment to advancing medical science, particularly in the area of targeted therapies.

Career Highlights

Vladimir Aladinskiy has established himself as a key figure in the realm of pharmaceutical research and development. Currently, he is employed at Insilico Medicine IP Limited, where he continues to push the boundaries of innovation and research in medicine. His work is vital in paving the way for new therapeutic options that can significantly benefit patients globally.

Collaborations

Throughout his career, Aladinskiy has collaborated with prominent professionals in his field, including Aleksandrs Zavoronkovs and Aleksandr M Aliper. These partnerships demonstrate his ability to work effectively within a team of experts, further enhancing his contributions to biomedical research.

Conclusion

Vladimir Aladinskiy stands out as an influential inventor whose work, characterized by multiple patents and collaborations, contributes to significant advancements in medical science. His efforts at Insilico Medicine IP Limited are set to redefine therapeutic approaches, showcasing the importance of innovation in addressing global health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…